Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Demand for Arthritis Care in America Outstrips Supply of Practicing Rheumatologists

Sharad Lakhanpal, MBBS, MD  |  May 18, 2017

May is National Arthritis Awareness Month. The ACR is committed to ensuring that arthritis and rheumatologic diseases are at the forefront of public awareness—and that better, safer treatments reach Americans in need. Fortunately, the federal government is also doing its part and has just released a major report on the national impact of arthritis. A…

Filed under:President's PerspectiveWorkforce Tagged with:AC&RAmerican College of Rheumatology (ACR)Arthritispatient carerheumatologistrheumatologyshortageTreatment

FDA Approves Oral Methotrexate; Plus Restrictions for 2 Analgesics in Children

Michele B. Kaufman, PharmD, BCGP  |  May 16, 2017

The FDA has approved a new formulation of methotrexate designed as an oral solution for pediatric patients. The agency has also recently introduced age restrictions for codeine and tramadol for children under age 12, citing their risks for slowed or difficult breathing and death…

Filed under:AnalgesicsConditionsDrug UpdatesPediatric Conditions Tagged with:breastfeedingcodeineFDAFood and Drug AdministrationinfantsMethotrexatePediatrictramadol

Fellows’ Forum: Why Rheumatology Fellows Should Get Involved with Advocacy

Alexandra Perel-Winkler, MD, & Christopher A. Mecoli, MD  |  May 16, 2017

Introduction Interest in rheumatology continues to grow, with more than 240 new adult and pediatric fellows to begin their training in the coming academic year. Given the broad and diverse career opportunities, it is an ACR goal to help guide trainees in their career decisions and professional development. Rheumatology fellowship often marks the transition from…

Filed under:Legislation & Advocacy Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Capitol HillCongressEducationFellowsFellows ForumFundingLegislationpolicyrheumatologistRheumPAC

Human Immune System Likened to Model of Military Efficiency

Thomas R. Collins  |  April 20, 2017

WASHINGTON, D.C.—Speaking at the 2016 ACR/ARHP Annual Meeting in a session titled ARHP: Immunology Boot Camp I: Basis of Targeted Therapy, a rheumatologist and immunology expert gave a guided tour of the immune system, described what can go wrong with it and outlined what physicians can do when it does. Troy Torgerson, MD, PhD, associate…

Filed under:Meeting ReportsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)B cellsImmunologyResearchrheumatologyT cell

ACR Leaders to Talk Policy with Congressional Leaders in D.C.

From the College  |  April 19, 2017

On May 11, ACR leaders will fly to Capitol Hill to meet with Congressional leaders on behalf of ACR and ARHP members. With so many pressing policy issues facing the medical community this year, we hope that you, too, will let your members of Congress know where you stand on the following issues: Support Medical…

Filed under:From the CollegeLegislation & AdvocacyProfessional Topics Tagged with:Capitol HillCDC Arthritis ProgramDepartment of Defense (DoD)FY2018 Defense Appropriations BillFY2018 Labor-HHA Appropriations BillIndependent Payment Advisory Board (IPAB)National Institutes of Health (NIH)policy issues

New Genetic Loci Identified, Epigenome Explored in Juvenile Idiopathic Arthritis

Thomas R. Collins  |  April 19, 2017

WASHINGTON, D.C.—Researchers have identified nine new genetic loci linked with juvenile idiopathic arthritis (JIA), along with evidence that at least some of them likely play a functional role, such as cytokine signaling and T cell expression. The findings were presented in an abstract session at the 2016 ACR/ARHP Annual Meeting, which also included a presentation…

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)epigeneticepigenomegenetic lociinflammatory syndromeJIAJuvenile idiopathic arthritisResearchrheumatology

The reasons rheumatologists choose hospital or academic employment vary. It comes down to what they value.

Rheumatologists Weigh Pros, Cons of Working in Academia

Karen Appold  |  April 19, 2017

Some rheumatologists find that an option other than working in a private practice makes the most sense for them. The reasons rheumatologists choose hospital or academic employment vary. Individual Choice When Lisa Criscione-Schreiber, MD, MEd, associate professor of medicine and rheumatology training program director, Duke University, Durham, N.C., was finishing her fellowship in 2003, she…

Filed under:Career DevelopmentEducation & Training Tagged with:AcademiabenefitsCareerhospitalphysicianPrivate practicerheumatologistrheumatology

seanbear/shutterstock.com

Volunteers Wanted to Join the ACR’s Committees, Board of Directors, Research Foundation

Sharad Lakhanpal, MBBS, MD  |  April 19, 2017

In 1974, President Nixon established a week in April to recognize the importance of volunteering. National Volunteer Week is scheduled for April 23–29 this year. At the College, we like to acknowledge and thank our volunteers year round. The mission of the College cannot be achieved without the time, effort, talent and dedication of our…

Filed under:Legislation & AdvocacyPresident's PerspectiveResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Board of directorsLeadershipmicrovolunteeringrheumatologistRheumatology Research FoundationVolunteer

Quality Measures Used to Assess Care, Improve Outcomes in Children, Adults with Rheumatic Diseases

Mary Beth Nierengarten  |  March 20, 2017

WASHINGTON, D.C.—In a session during the 2016 ACR/ARHP Annual Meeting, aptly called Quality Measures and Quality of Care I, a panel of experts presented information on a number of programs underway in rheumatology using quality measures to both assess and improve patient outcomes. Leading off were two presentations on programs using quality measures to improve…

Filed under:ConditionsMeeting ReportsPediatric ConditionsQuality Assurance/Improvement Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)patient carePediatricPractice ManagementQualityRheumatic Diseaserheumatologistrheumatology

Cancer Risk for Patients with Juvenile Idiopathic Arthritis Taking TNF Inhibitors

Thomas R. Collins  |  March 20, 2017

WASHINGTON, D.C.—Juvenile idiopathic arthritis (JIA) patients taking TNF inhibitors don’t develop new cancers at a higher rate than JIA patients who don’t take TNF inhibitors, according to the largest study so far conducted to study the possible link. The findings were reported at the 2016 ACR/ARHP Annual Meeting in an abstract session that also included…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)CancerinhibitorJuvenile idiopathic arthritisPediatricsrateResearchrheumatologyriskTNFTreatment

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 109
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences